"The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our current capabilities and platforms in this important market," said Mark Smedley, president of Life Technologies, Asia Pacific Japan region.
"The scientific community in Asia Pacific is growing at a rapid rate," said Mark Smedley, President of Asia Pacific and Japan for Life Technologies. "By establishing the Instrument Center of Excellence in Singapore we are providing our global customers innovative technologies more efficiently, while helping them advance their research even faster."
Integration Team Will Drive Realization of $175 Million in > Expected Operating Profit Synergies by 2011, $60 Million in 2009 CARLSBAD, Calif.--(BUSINESS WIRE)--June 20, 2008--Invitrogen Corporation (NASDAQ: IVGN) today announced that Mark Smedley, Invitrogen's Global Head of Operations, has been appointed to lead the integration team for the combination of Invitrogen and Applera's Applied Biosystems Group (NYSE: ABI).Mr. Smedley brings twenty years of experience in life scien...
"The acquisition of KDR Biotech is in line with Life's Asia-Pacific Japan strategy to further develop customer relationships, improve the customer experience and increase revenue in the fast-growing South Korean biotechnology market, in addition to Life's overall strategy of expanding our footprint into strong growth and emerging markets," said Mark Smedley, president of Life Technologies, Asia-Pacific Japan region.
"The acquisition of LSK is in line with our go-direct strategy in South Korea and builds on our current capabilities and platforms in this important market," Mark Smedley, president of Life Technologies, Asia Pacific Japan region said in a statement.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.